Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for endoscopy sedation
IRCT20220221054090N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Sedation level, Hemodynamic instability and 1 more. Started Jun 2022; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20220221054090N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220221054090N1.